LUPIN
|
The Current P/B Ratio of LUPIN is 4.62.
| Share Price | ₹2,266.8 | Jun 17,2026 |
| Market Cap | ₹103,638.1 Cr | |
| Book Value | ₹22,448.3 Cr | Mar2026 - Consolidated Results |
| Price/Book | 4.62x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of LUPIN
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹103,638.1 Cr] as on Jun 17,2026
(/) Book Value [ ₹22,448.3 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 4.62x ]
Thus, for LUPIN , the investors are currently willing to pay '4.62 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of LUPIN !
The chart below summarizes the trend in P/B Ratio of LUPIN over the last five years.
Historical PB (Price/Book ) ratio chart of LUPIN
PB Ratio Performance Analysis for LUPIN
- LUPIN 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.84x.
- LUPIN 's operated at median p/b ratio of 3.4x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LUPIN 's p/b ratio peaked in Mar2025 at 5.4x.
- LUPIN 's p/b ratio hit its five-year low in Mar2023 of 2.39x.
How does LUPIN 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| LUPIN | 22,448.30 | 4.62 | 103,638.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.23 | 436,667.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 10.55 | 176,805.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 17.95 | 150,554.0 |
| CIPLA LTD | 34,369.40 | 3.17 | 109,120.0 |
| DR REDDYS LABORATORIES LTD | 37,891.50 | 2.80 | 105,920.0 |
| MANKIND PHARMA LTD | 16,300.30 | 5.99 | 97,611.6 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 3.94 | 106,812.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.16 | 81,824.5 |
| LAURUS LABS LTD | 5,275.08 | 14.02 | 73,957.5 |
| BIOCON LTD | 34,031.80 | 1.96 | 66,732.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs LUPIN 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 1.96x |
| Max industry PB | 17.95x |
| Median industry PB | 4.62x |
| Average industry PB | 6.58x |
You may also like the below Video Courses